Molecular Imaging 2017

Clinical Trials:

 Safety/Toxicity/Dosage Phase I

Phase II

Phase III

 Randomisation  Tested vs standard treatment

 Therapy effectiveness  Safety

Question: Is the therapy safe & is there biological activity?

Question: Does the therapy work sufficiently well?

Question: How well does the therapy compare to what we have?

Go/No go

Go/No go

Response criteria